Free provider profile

ADLINE GHAZI, M.D.

NPI 1609033869
Individual
Internal Medicine, Endocrinology, Diabetes & Metabolism
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like ADLINE GHAZI?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What ADLINE GHAZI prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Ozempic
  • Mounjaro
  • Jardiance
  • Trulicity
  • Tresiba Flextouch U-100

See all endocrinologists in DC who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

202-741-3333

Practice address

2150 PENNSYLVANIA AVE NW SUITE 5-404, WASHINGTON, DC, 20037

Registry updated
2011-03-22
NPI issued
2008-05-16
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

2150 PENNSYLVANIA AVE NW SUITE 5-404, WASHINGTON, DC, 20037

202-741-3333

Single practice location

Enumerated 2008-05-16

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record last updated 15 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

2,916

Medicare patients

413

Part D drug cost

$1,499,941

Brand-name share

45.4%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Ozempic (Semaglutide)311$530,614
Trulicity (Dulaglutide)122$180,776
Mounjaro (Tirzepatide)142$180,640
Jardiance (Empagliflozin)129$176,626
Tymlos (Abaloparatide)14$50,501
Tresiba Flextouch U-100 (Insulin Degludec)66$38,932
Farxiga (Dapagliflozin Propanediol)33$35,626
Rybelsus (Semaglutide)20$28,348

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across DC — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.